COMPANY

Echelon Biosciences

HQ: Salt Lake City, UT source · echelon-inc.com ↗ · Mountain

Status: Acquired, now part of VION Biosciences · How status works

Service / Tools company

Contact Opens the company's own website

Profile checked Oct 10, 2026

50NIH grants

NIH awards 50

Annual award amounts. Total $11.2M.

Sep 18, 2024 NIH award 1R41AA031429-01 FY2024: supplement or administrative line (under $1,000); activity R41 (STTR); PI NEILSEN, PAUL O; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Innovative Point-of-Care Solutions for source ↗
Dec 27, 2019 NIH award 5R43GM131444-02 FY2020: $150,000 awarded for that fiscal year; activity R43 (SBIR); PI CHAN, FOK VUN; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Accessible And Robust Tools for Gly source ↗
Dec 25, 2018 NIH award 1R43GM131444-01 FY2019: $150,000 awarded for that fiscal year; activity R43 (SBIR); PI CHAN, FOK VUN; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Accessible And Robust Tools for Gly source ↗
2016 NIH contract (government contract; not a grant and not an investment round) 275201400007C-2-0-1 FY2016: $29,261 awarded for that fiscal year; activity N44 (OTHER_NIH); PI NIELSEN, PAUL, PH.D.; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT source ↗
Sep 10, 2015 NIH award 5R44FD004052-03 FY2015: $426,154 awarded for that fiscal year; activity R44 (SBIR); PI CHAN, FOK VUN; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. New Approach to Phospholipidosis Pr source ↗
Sep 4, 2014 NIH award 2R44FD004052-02 FY2014: $449,426 awarded for that fiscal year; activity R44 (SBIR); PI RZEPECKI, PIOTR W; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. New Approach to Phospholipidosi source ↗
Aug 6, 2014 NIH award 1R43CA189390-01 FY2014: $224,334 awarded for that fiscal year; activity R43 (SBIR); PI GUNTHER, DERRICK; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Targeting ether lipid biosynthes source ↗
2014 NIH contract (government contract; not a grant and not an investment round) 275201400007C-0-0-1 FY2014: $625,360 awarded for that fiscal year; activity N44 (OTHER_NIH); PI NIELSEN, PAUL, PH.D.; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, U source ↗
2013 NIH contract (government contract; not a grant and not an investment round) 275201200001C-3-0-1 FY2013: $520,907 awarded for that fiscal year; activity N44 (OTHER_NIH); PI NEILSEN, PH.D., PAUL; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, U source ↗
2012 NIH contract (government contract; not a grant and not an investment round) 275201200001C-1-0-1 FY2012: $548,090 awarded for that fiscal year; activity N44 (OTHER_NIH); PI NEILSEN, PH.D., PAUL; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, U source ↗
Sep 1, 2011 NIH award 1R43FD004052-01 FY2011: $149,884 awarded for that fiscal year; activity R43 (SBIR); PI RZEPECKI, PIOTR W; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. New Approach to Phospholipidosi source ↗
Jun 25, 2010 NIH award 1R43HD066993-01 FY2010: $248,864 awarded for that fiscal year; activity R43 (SBIR); PI NEILSEN, PAUL O; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Anti-Phospholipid Multiplex For P source ↗
Mar 15, 2010 NIH award 4R42GM086925-02 FY2010: $277,549 awarded for that fiscal year; activity R42 (STTR); PI WANG, BINGHE; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Aptamer-based Glycomics Tools source ↗
Mar 10, 2009 NIH award 5R43AI077220-02 FY2009: $299,834 awarded for that fiscal year; activity R43 (SBIR); PI TESTA, CHARLES; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Methylerythritol Phosphate Pathway source ↗
Feb 26, 2009 NIH award 1R42GM086925-01 FY2009: $277,549 awarded for that fiscal year; activity R42 (STTR); PI WANG, BINGHE; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Aptamer-based Glycomics Tools source ↗
Jan 9, 2009 NIH award 5R43AI078554-02 FY2009: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI TESTA, CHARLES; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Methylerythritol Phosphate Pathway source ↗
May 12, 2008 NIH award 1R43GM084502-01 FY2008: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI FERGUSON, COLIN G; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Fluorogenic Assays for Measurin source ↗
Apr 14, 2008 NIH award 1R43AI077220-01 FY2008: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI TESTA, CHARLES; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Methylerythritol Phosphate Pathway source ↗
Jan 31, 2008 NIH award 1R43AI078554-01 FY2008: $292,461 awarded for that fiscal year; activity R43 (SBIR); PI TESTA, CHARLES; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Methylerythritol Phosphate Pathway source ↗
Jan 14, 2008 NIH award 1R43NS049920-01A2 FY2008: $93,749 awarded for that fiscal year; activity R43 (SBIR); PI RZEPECKI, PIOTR W; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Discovery of Inositol(1,4,5)tr source ↗
May 31, 2004 NIH award 5R44GM065683-03 FY2004: $310,211 awarded for that fiscal year; activity R44 (SBIR); PI FERGUSON, COLIN G; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Liposome Overlays For Protein-L source ↗
Feb 11, 2004 NIH award 5R43CA099434-02 FY2004: $250,000 awarded for that fiscal year; activity R43 (SBIR); PI CHAKRAVARTY, LEENA; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Discovery of Antagonists of Ph source ↗
Aug 15, 2003 NIH award 1R43GM069074-01 FY2003: $100,152 awarded for that fiscal year; activity R43 (SBIR); PI NEILSEN, PAUL O; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Hybrid Phospholipid-Phosphoinosit source ↗
Jun 27, 2003 NIH award 1R43GM068177-01 FY2003: $116,150 awarded for that fiscal year; activity R43 (SBIR); PI BROWN, MARK J; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Intracellular Localization of Prote source ↗
2003 NIH award 1R43CA099434-01 FY2003: $250,000 awarded for that fiscal year; activity R43 (SBIR); PI CHAKRAVARTY, LEENA; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Discovery of Antagonists of Ph source ↗
2003 NIH award 1R43AI053929-01 FY2003: $109,120 awarded for that fiscal year; activity R43 (SBIR); PI BROWN, MARK J; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Screen for Isoprenoid Production in source ↗
2003 NIH award 5R44CA081835-04 FY2003: $351,246 awarded for that fiscal year; activity R44 (SBIR); PI DREES, BETH E; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Phosphoinositide 3-Kinase Assays in source ↗
2003 NIH award 2R44GM065683-02 FY2003: $374,695 awarded for that fiscal year; activity R44 (SBIR); PI FERGUSON, COLIN G; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Liposome Overlays For Protein-L source ↗
2003 NIH award 5R43CA096051-02 FY2003: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI FENG, LI; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Lipid Microarrays source ↗
2003 NIH award 1R43GM067365-01 FY2003: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI FENG, LI; recipient as written: ECHELON BIOSCIENCES, INC., SALT LAKE CITY, UT. Fluorogenic Assays for Phospholipid Dete source ↗